Romina Malerba
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Romina Malerba has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Alba Rebecca Hernandez Guzman
Temple University Hospital
1 shared publication Ashish Bains
Temple University Hospital
1 shared publication- Daniela Proca
Temple University, Philadelphia, PA
1 shared publication Israh Akhtar
Temple University Hospital
1 shared publicationJalil Nasibli
Temple University Hospital
1 shared publicationJulius Nani
Lewis Katz Medical School, Temple University, Philadelphia, PA, USA
1 shared publication
Latest Publications
- Open Access
- 22 August 2026
- Published by Elsevier in Radiology Case Reports
- Vol. 21 (11) , 5520-5525
Low-grade osteogenic tumor with secondary aneurysmal bone cyst: Distinguishing osteoblastoma from low-grade osteosarcoma in the setting of noncanonical molecular findings
- 22 August 2026
- Published by Elsevier in Radiology Case Reports
- Vol. 21 (11) , 5520-5525
Open AccessLow-grade osteogenic tumor with secondary aneurysmal bone cyst: Distinguishing osteoblastoma from low-grade osteosarcoma in the setting of noncanonical molecular findings
- 4 May 2026
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 34 (6) , 1673-1678
Rosai–Dorfman Disease of the Breast: A Case Series and Review of the Literature
Context: Rosai–Dorfman disease is a rare histiocytic disorder that primarily affects lymph nodes but may present at extranodal sites. Breast involvement is exceptionally rare and often mimics malignancy on clinical and imaging studies, leading to diagnostic challenges. Objective: To describe the clinical, radiologic, and pathologic features of breast Rosai–Dorfman disease and review management outcomes. Design: We retrospectively reviewed all instances of breast Rosai–Dorfman disease diagnosed at our institution over a 14-month period. Clinical records, imaging studies, histopathology, treatment, and follow-up data were analyzed. Results: A total of three patients were diagnosed with Rosai–Dorfman disease of the breast. All three patients were women aged 22 to 71 years. Two presented with palpable breast masses, and one patient had a mass that was incidentally detected on chest computed tomography. Imaging demonstrated irregular masses categorized as Breast Imaging Reporting and Data System (BI-RADS) category 4–5, suspicious for carcinoma. Histopathologic examination showed dense lymphoplasmacytic infiltrates with histiocytes exhibiting emperipolesis and immunoreactivity for S100, CD68, and CD163, with negative CD1A staining. Two patients underwent excision, and one was managed conservatively. At follow-up, all patients remained disease-free without recurrence or systemic involvement. Conclusions: Breast Rosai–Dorfman disease is a rare benign entity that closely mimics carcinoma both clinically and radiologically. Accurate diagnosis relies on histopathologic evaluation with immunohistochemistry. Management may range from observation to surgical excision depending on lesion size and symptoms. Awareness of this presentation is essential to prevent misdiagnosis and overtreatment.
- 4 May 2026
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 34 (6) , 1673-1678
Rosai–Dorfman Disease of the Breast: A Case Series and Review of the Literature
Context: Rosai–Dorfman disease is a rare histiocytic disorder that primarily affects lymph nodes but may present at extranodal sites. Breast involvement is exceptionally rare and often mimics malignancy on clinical and imaging studies, leading to diagnostic challenges. Objective: To describe the clinical, radiologic, and pathologic features of breast Rosai–Dorfman disease and review management outcomes. Design: We retrospectively reviewed all instances of breast Rosai–Dorfman disease diagnosed at our institution over a 14-month period. Clinical records, imaging studies, histopathology, treatment, and follow-up data were analyzed. Results: A total of three patients were diagnosed with Rosai–Dorfman disease of the breast. All three patients were women aged 22 to 71 years. Two presented with palpable breast masses, and one patient had a mass that was incidentally detected on chest computed tomography. Imaging demonstrated irregular masses categorized as Breast Imaging Reporting and Data System (BI-RADS) category 4–5, suspicious for carcinoma. Histopathologic examination showed dense lymphoplasmacytic infiltrates with histiocytes exhibiting emperipolesis and immunoreactivity for S100, CD68, and CD163, with negative CD1A staining. Two patients underwent excision, and one was managed conservatively. At follow-up, all patients remained disease-free without recurrence or systemic involvement. Conclusions: Breast Rosai–Dorfman disease is a rare benign entity that closely mimics carcinoma both clinically and radiologically. Accurate diagnosis relies on histopathologic evaluation with immunohistochemistry. Management may range from observation to surgical excision depending on lesion size and symptoms. Awareness of this presentation is essential to prevent misdiagnosis and overtreatment.